Security key
08205P100
- Security type / class
- Equity / COM
- Total 13F shares
- 625,000
- Total 13F value
- $4,368,750
- Share change
- +625,000
- SEC-reported price per share
- $6.99
- Number of holders
- 1
- Value change
- +$4,368,750
- Number of buys
- 1
Report period
Q2 2024
Institutions
1
Top holders
1
BNTC full security history
Ownership snapshot
Full 13F holder table
Benitec Biopharma Inc. SEC filings
Benitec Biopharma Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of BNTC - BENITEC BIOPHARMA INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Steven Michael Oliveira
Disclosed value leader
Steven Michael Oliveira
Comparable rows
0/14
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $3,044,300
14 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
Steven Michael Oliveira has the largest disclosed position value at $3.04M.
0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Steven Michael Oliveira's linked filing trail.
Disclosed position value
Top 5
Steven Michael Oliveira
$3.04M
FRANKLIN TEMPLETON INC
$3.01M
Janus Henderson Group Ltd.
$1.27M
MONTANOVA CAPITAL, LLC
$1.07M
ADAGE CAPITAL PARTNERS GP, L.L.C.
$993.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Steven Michael Oliveira |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,044,300
1,000,000 shares
|
— | 28 Apr 2021 |
| FRANKLIN TEMPLETON INC |
13F
Company
|
—
denominator unverified
|
$3,012,147
588,310 shares
|
— | 31 Mar 2024 |
| Janus Henderson Group Ltd. |
13F
Company
|
—
denominator unverified
|
$1,266,463
244,491 shares
|
— | 31 Mar 2024 |
| MONTANOVA CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$1,072,155
204,220 shares
|
— | 31 Mar 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
—
denominator unverified
|
$993,237
189,188 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$87,680
16,701 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
625,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
0
Q2 2024 holders
1
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|